Q3 Revenue Jumps 28% as Losses Narrow Sharply; CEO Warns of Softening P&C Market Into 2027
OSG sits 36% above its 52-week low of $3.88.
Summary
Octave posted Q3 2026 total revenue of $85.3 million, up 28% from $66.6 million a year ago, driven by 35% growth in Insurance Distribution (22.6% organic) and 52% earned premium growth at Everspan. The bottom line improved materially: net loss from continuing operations attributable to shareholders narrowed to $(13.8) million from $(31.7) million, a 3Q loss of 31c per share, and Adjusted EBITDA to shareholders swung to $3.3 million from $(2.9) million. Specialty P&C turned the corner, with Everspan's Adjusted EBITDA to shareholders at $2.2 million versus less than $0.1 million a year ago and the combined ratio improving to 100.6% from 112.9%. The caveat is forward-looking: CEO Claude LeBlanc said the P&C market has become more competitive and expects softening to continue into 2027, which tempers the growth story. This follows the October 23 news that Everspan agreed to sell its redundant Providence Washington shell to Falvey Insurance Group, part of the effort to simplify the structure and shore up capital. The Q3 earnings call is scheduled for November 10 at 8:30am ET.
At the time of this announcement, OSG was trading at $5.27 on NYSE in the Finance sector, with a market capitalization of approximately $237.4M. The 52-week trading range was $3.88 to $10.38. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.